Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril

CompletedOBSERVATIONAL

Enrollment

1,909

Participants

Timeline

Start Date

November 14, 2018

Primary Completion Date

October 24, 2019

Study Completion Date

October 24, 2019

Conditions

Arterial HypertensionCHD - Coronary Heart Disease

Interventions

DRUG

bisoprolol/perindopril FDC

the first and only single-pill combination of beta-blocker and ACE inhibitor

Trial Locations (1)

FSBI NMIC of Cardiology of the Ministry of Health of Russia, Moscow

All Listed Sponsors

lead

Servier Russia

INDUSTRY

NCT03730116 - Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril | Biotech Hunter | Biotech Hunter